{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T23:34:50Z","timestamp":1781048090885,"version":"3.54.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100020171","name":"Foreign, Commonwealth and Development Office","doi-asserted-by":"publisher","award":["204139"],"award-info":[{"award-number":["204139"]}],"id":[{"id":"10.13039\/501100020171","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020171","name":"Foreign, Commonwealth and Development Office","doi-asserted-by":"publisher","award":["204139"],"award-info":[{"award-number":["204139"]}],"id":[{"id":"10.13039\/501100020171","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020171","name":"Foreign, Commonwealth and Development Office","doi-asserted-by":"publisher","award":["204139"],"award-info":[{"award-number":["204139"]}],"id":[{"id":"10.13039\/501100020171","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020171","name":"Foreign, Commonwealth and Development Office","doi-asserted-by":"publisher","award":["204139"],"award-info":[{"award-number":["204139"]}],"id":[{"id":"10.13039\/501100020171","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020171","name":"Foreign, Commonwealth and Development Office","doi-asserted-by":"publisher","award":["204139"],"award-info":[{"award-number":["204139"]}],"id":[{"id":"10.13039\/501100020171","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020171","name":"Foreign, Commonwealth and Development Office","doi-asserted-by":"publisher","award":["204139"],"award-info":[{"award-number":["204139"]}],"id":[{"id":"10.13039\/501100020171","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020171","name":"Foreign, Commonwealth and Development Office","doi-asserted-by":"publisher","award":["204139"],"award-info":[{"award-number":["204139"]}],"id":[{"id":"10.13039\/501100020171","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020171","name":"Foreign, Commonwealth and Development Office","doi-asserted-by":"publisher","award":["204139"],"award-info":[{"award-number":["204139"]}],"id":[{"id":"10.13039\/501100020171","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020171","name":"Foreign, Commonwealth and Development Office","doi-asserted-by":"publisher","award":["204139"],"award-info":[{"award-number":["204139"]}],"id":[{"id":"10.13039\/501100020171","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020171","name":"Foreign, Commonwealth and Development Office","doi-asserted-by":"publisher","award":["204139"],"award-info":[{"award-number":["204139"]}],"id":[{"id":"10.13039\/501100020171","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020171","name":"Foreign, Commonwealth and Development Office","doi-asserted-by":"publisher","award":["204139"],"award-info":[{"award-number":["204139"]}],"id":[{"id":"10.13039\/501100020171","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020171","name":"Foreign, Commonwealth and Development Office","doi-asserted-by":"publisher","award":["204139"],"award-info":[{"award-number":["204139"]}],"id":[{"id":"10.13039\/501100020171","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill & Melinda Gates Foundation","doi-asserted-by":"crossref","award":["OPP1107113"],"award-info":[{"award-number":["OPP1107113"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000865","name":"Bill & Melinda Gates Foundation","doi-asserted-by":"crossref","award":["OPP1107113"],"award-info":[{"award-number":["OPP1107113"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000865","name":"Bill & Melinda Gates Foundation","doi-asserted-by":"crossref","award":["OPP1107113"],"award-info":[{"award-number":["OPP1107113"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000865","name":"Bill & Melinda Gates Foundation","doi-asserted-by":"crossref","award":["OPP1107113"],"award-info":[{"award-number":["OPP1107113"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000865","name":"Bill & Melinda Gates Foundation","doi-asserted-by":"crossref","award":["OPP1107113"],"award-info":[{"award-number":["OPP1107113"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000865","name":"Bill & Melinda Gates Foundation","doi-asserted-by":"crossref","award":["OPP1107113"],"award-info":[{"award-number":["OPP1107113"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000865","name":"Bill & Melinda Gates Foundation","doi-asserted-by":"crossref","award":["OPP1107113"],"award-info":[{"award-number":["OPP1107113"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000865","name":"Bill & Melinda Gates Foundation","doi-asserted-by":"crossref","award":["OPP1107113"],"award-info":[{"award-number":["OPP1107113"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000865","name":"Bill & Melinda Gates Foundation","doi-asserted-by":"crossref","award":["OPP1107113"],"award-info":[{"award-number":["OPP1107113"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000865","name":"Bill & Melinda Gates Foundation","doi-asserted-by":"crossref","award":["OPP1107113"],"award-info":[{"award-number":["OPP1107113"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000865","name":"Bill & Melinda Gates Foundation","doi-asserted-by":"crossref","award":["OPP1107113"],"award-info":[{"award-number":["OPP1107113"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000865","name":"Bill & Melinda Gates Foundation","doi-asserted-by":"crossref","award":["OPP1107113"],"award-info":[{"award-number":["OPP1107113"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Malar J"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Current treatment guidelines for radical cure of\n                      <jats:italic>Plasmodium vivax<\/jats:italic>\n                      malaria recommend the use of 8-aminoquinolines, which can result in life-threatening complications in people with glucose-6-phsophate dehydrogenase (G6PD) deficiency. Testing for this condition is recommended prior to administering such drugs. The Wondfo G6PD\/Hb Test (Guangzhou Wondfo Biotech Co., Ltd., China) is a novel, quantitative point-of-care (POC) G6PD test that may help decentralize testing, expanding access to safe treatment options.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Two studies were conducted: a retrospective diagnostic accuracy study on frozen venous whole blood specimens and a prospective matrix equivalency study. First, 300 frozen specimens from Mae Sot, Thailand were tested from July\u2013August 2022 using the Wondfo test in laboratory and simulated field conditions. Reference testing for G6PD and Hb (spectrophotometer [Pointe Scientific, USA] and HemoCue [HemoCue AB, Sweden], respectively) was completed in the laboratory. Usability was evaluated among 10 intended users. Next, 225 participants were enrolled into a prospective matrix equivalency study from March\u2013May 2023 in Memphis, Tennessee, USA. The Wondfo test was conducted at the POC with fingerstick capillary blood, and Wondfo and HemoCue tests were completed on fresh venous (K\n                      <jats:sub>2<\/jats:sub>\n                      EDTA) blood within 12\u00a0h. Remaining specimens were shipped to PATH for repeat Wondfo and reference testing.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The Wondfo G6PD measurement showed strong correlation under both laboratory and field conditions (R\n                      <jats:sup>2<\/jats:sup>\n                      &gt;0.9). The area under the curve was 1.00 for deficient (95% CI: 1.00\u20131.00) and 0.99 for intermediate individuals (95% CI: 0.99\u20131.00). Sensitivity was high (1.00) across all conditions and groups (lower bound of the 95% CI \u22650.85). Good correlation was observed in both capillary and fresh venous blood against the reference and each other (R\n                      <jats:sup>2<\/jats:sup>\n                      &gt;0.75). McNemar\u2019s test showed no significant differences in classification between venous and capillary specimens. The Wondfo test achieved 98.2% (95%CI: 95.5\u201399.5%) overall agreement. All usability participants successfully completed quality control and test procedures, rating the test system highly for ease of use.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The Wondfo G6PD\/Hb Test demonstrates good diagnostic performance using current manufacturer thresholds across various conditions and both venous and capillary specimens. Comparable performance in both specimen types supports matrix equivalence. Usability is acceptable for end users, though refinements were recommended.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12936-025-05436-0","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T05:24:36Z","timestamp":1751347476000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Evaluation of the Wondfo G6PD\/Hb Test for glucose-6-phosphate dehydrogenase deficiency: preliminary performance, matrix equivalence, and usability"],"prefix":"10.1186","volume":"24","author":[{"given":"Rebecca K.","family":"Green","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Zobrist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gornpan","family":"Gornsawun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paw Khu","family":"Moo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laypaw","family":"Archasuksan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huyen","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huong","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cindy S.","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Gerth-Guyette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Podjanee","family":"Jittamala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Nosten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sampa","family":"Pal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Germana","family":"Bancone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gonzalo J.","family":"Domingo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,1]]},"reference":[{"key":"5436_CR1","unstructured":"WHO. World malaria report 2023 [Internet]. Geneva, World Health Organization, 2023. [cited 2024 Oct 10]. Available from: https:\/\/www.who.int\/publications\/i\/item\/9789240086173"},{"key":"5436_CR2","doi-asserted-by":"publisher","first-page":"e1003799","DOI":"10.1371\/journal.pmed.1003799","volume":"18","author":"KE Battle","year":"2021","unstructured":"Battle KE, Baird JK. The global burden of Plasmodium vivax malaria is obscure and insidious. PLoS Med. 2021;18:e1003799.","journal-title":"PLoS Med."},{"key":"5436_CR3","unstructured":"WHO. Guidelines for malaria. [Internet]. Geneva, World Health Organization,2024 [cited 2024 Dec 11]. Available from: https:\/\/www.who.int\/publications\/i\/item\/guidelines-for-malaria"},{"key":"5436_CR4","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1056\/NEJMoa1710775","volume":"380","author":"MVG Lacerda","year":"2019","unstructured":"Lacerda MVG, Llanos-Cuentas A, Krudsood S, Lon C, Saunders DL, Mohammed R, et al. Single-dose tafenoquine to prevent relapse of Plasmodium vivax malaria. N Engl J Med. 2019;380:215\u201328.","journal-title":"N Engl J Med."},{"key":"5436_CR5","doi-asserted-by":"publisher","first-page":"34","DOI":"10.3390\/ijns4040034","volume":"4","author":"A Anderle","year":"2018","unstructured":"Anderle A, Bancone G, Domingo GJ, Gerth-Guyette E, Pal S, Satyagraha AW. Point-of-care testing for G6PD deficiency: opportunities for screening. Int J Neonatal Screen. 2018;4:34.","journal-title":"Int J Neonatal Screen."},{"key":"5436_CR6","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1093\/inthealth\/ihy060","volume":"11","author":"GJ Domingo","year":"2019","unstructured":"Domingo GJ, Advani N, Satyagraha AW, Sibley CH, Rowley E, Kalnoky M, et al. Addressing the gender-knowledge gap in glucose-6-phosphate dehydrogenase deficiency: challenges and opportunities. Int Health. 2019;11:7\u201314.","journal-title":"Int Health."},{"key":"5436_CR7","first-page":"21","volume":"5","author":"CS Chu","year":"2020","unstructured":"Chu CS, Bancone G, Kelley M, Advani N, Domingo GJ, Cutiongo-de Paz EM, et al. Optimizing G6PD testing for Plasmodium vivax case management and beyond: why sex, counseling, and community engagement matter. Wellcome Open Res. 2020;5:21.","journal-title":"Wellcome Open Res."},{"key":"5436_CR8","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.3390\/pathogens11111328","volume":"11","author":"JD Brito-Sousa","year":"2022","unstructured":"Brito-Sousa JD, Murta F, Vitor-Silva S, Sampaio V, Mendes M, Souza B, et al. Quantitative G6PD deficiency screening in routine malaria diagnostic units in the Brazilian Amazon (SAFEPRIM): an operational mixed-methods study. Pathogens. 2022;11:1328.","journal-title":"Pathogens."},{"key":"5436_CR9","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S1473-3099(24)00074-4","volume":"24","author":"M Brito","year":"2024","unstructured":"Brito M, Rufatto R, Brito-Sousa JD, Murta F, Sampaio V, Balieiro P, et al. Operational effectiveness of tafenoquine and primaquine for the prevention of Plasmodium vivax recurrence in Brazil: a retrospective observational study. Lancet Infect Dis. 2024;24:629\u201338.","journal-title":"Lancet Infect Dis."},{"key":"5436_CR10","doi-asserted-by":"publisher","first-page":"e467","DOI":"10.1016\/S2214-109X(23)00542-9","volume":"12","author":"M Brito","year":"2024","unstructured":"Brito M, Rufatto R, Murta F, Sampaio V, Balieiro P, Ba\u00eda-Silva D, et al. Operational feasibility of Plasmodium vivax radical cure with tafenoquine or primaquine following point-of-care, quantitative glucose-6-phosphate dehydrogenase testing in the Brazilian Amazon: a real-life retrospective analysis. Lancet Glob Health. 2024;12:e467-77.","journal-title":"Lancet Glob Health."},{"key":"5436_CR11","doi-asserted-by":"publisher","first-page":"e0275822","DOI":"10.1371\/journal.pone.0275822","volume":"17","author":"ST Kheang","year":"2022","unstructured":"Kheang ST, Ridley R, Ngeth E, Ir P, Ngor P, Sovannaroth S, et al. G6PD testing and radical cure for Plasmodium vivax in Cambodia: a mixed methods implementation study. PLoS One. 2022;17:e0275822.","journal-title":"PLoS One."},{"key":"5436_CR12","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1186\/s12936-022-04300-9","volume":"21","author":"B Adhikari","year":"2022","unstructured":"Adhikari B, Tripura R, Dysoley L, Callery JJ, Peto TJ, Heng C, et al. Glucose 6 Phosphate Dehydrogenase (G6PD) quantitation using biosensors at the point of first contact: a mixed method study in Cambodia. Malar J. 2022;21:282.","journal-title":"Malar J."},{"key":"5436_CR13","unstructured":"WHO. Public Report for STANDARD G6PD Test (PQDx 0581-117-00) - Prequalification of Medical Products (IVDs, Medicines, Vaccines and Immunization Devices, Vector Control) [Internet]. [cited 2025 Mar 19]. Available from: https:\/\/extranet.who.int\/prequal\/WHOPR\/public-report-standard-g6pd-test-pqdx-0581-117-00"},{"key":"5436_CR14","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/S0140-6736(08)60073-2","volume":"371","author":"MD Cappellini","year":"2008","unstructured":"Cappellini MD, Fiorelli G. Glucose-6-phosphate dehydrogenase deficiency. Lancet. 2008;371:64\u201374.","journal-title":"Lancet."},{"key":"5436_CR15","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1186\/1475-2875-12-391","volume":"12","author":"GJ Domingo","year":"2013","unstructured":"Domingo GJ, Satyagraha AW, Anvikar A, Baird K, Bancone G, Bansil P, et al. G6PD testing in support of treatment and elimination of malaria: recommendations for evaluation of G6PD tests. Malar J. 2013;12:391.","journal-title":"Malar J."},{"key":"5436_CR16","unstructured":"WHO. Target product profiles for tests for glucose-6-phosphate dehydrogenase activity [Internet]. [cited 2024 Feb 2]. Available from: https:\/\/www.who.int\/publications-detail-redirect\/9789240062962"},{"key":"5436_CR17","first-page":"189","volume-title":"Usability Evaluation in Industry","author":"J Brooke","year":"1996","unstructured":"Brooke J. SUS - a quick and dirty usability scale. In: Usability Evaluation in Industry. UK: Taylor & Francis; 1996. p. 189\u201394."},{"key":"5436_CR18","doi-asserted-by":"publisher","first-page":"e0009649","DOI":"10.1371\/journal.pntd.0009649","volume":"15","author":"S Zobrist","year":"2021","unstructured":"Zobrist S, Brito M, Garbin E, Monteiro WM, Freitas SC, Macedo M, et al. Evaluation of a point-of-care diagnostic to identify glucose-6-phosphate dehydrogenase deficiency in Brazil. PLoS Negl Trop Dis. 2021;15:e0009649.","journal-title":"PLoS Negl Trop Dis."},{"key":"5436_CR19","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1093\/ajcp\/aqaa040","volume":"154","author":"EC Calvaresi","year":"2020","unstructured":"Calvaresi EC, Genzen JR. Evaluating percentage-based reporting of glucose-6-phosphate dehydrogenase (G6PD) enzymatic activity. Am J Clin Pathol. 2020;154:248\u201354.","journal-title":"Am J Clin Pathol."},{"key":"5436_CR20","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/1471-2105-12-77","volume":"12","author":"X Robin","year":"2011","unstructured":"Robin X, Turck N, Hainard A, Tiberti N, Lisacek F, Sanchez JC, et al. pROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinformatics. 2011;12:77.","journal-title":"BMC Bioinformatics."},{"key":"5436_CR21","unstructured":"Lehnert B. BlandAltmanLeh: Plots (Slightly Extended) Bland-Altman Plots. R package version 0.3.1; 2015. Available from: https:\/\/CRAN.R-project.org\/package=BlandAltmanLeh"},{"key":"5436_CR22","unstructured":"Stevenson M. Sergeant E. epiR: Tools for the Analysis of Epidemiological Data. R package version 2.0.84; 2025. Available from: https:\/\/CRAN.R-project.org\/package=epiR"},{"key":"5436_CR23","doi-asserted-by":"crossref","unstructured":"Wickham H. ggplot2: Elegant Graphics for Data Analysis. Springer-Verlag New York; 2016. Available from: https:\/\/ggplot2.tidyverse.org","DOI":"10.1007\/978-3-319-24277-4_9"},{"key":"5436_CR24","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1002\/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3","volume":"3","author":"WJ Youden","year":"1950","unstructured":"Youden WJ. Index for rating diagnostic tests. Cancer. 1950;3:32\u20135.","journal-title":"Cancer."},{"key":"5436_CR25","unstructured":"WHO. Guideline on haemoglobin cutoffs to define anaemia in individuals and populations [Internet]. [cited 2024 Nov 15]. Available from: https:\/\/www.who.int\/publications\/i\/item\/9789240088542"},{"key":"5436_CR26","first-page":"114","volume":"4","author":"A Bangor","year":"2009","unstructured":"Bangor A, Kortum P, Miller J. Determining what individual SUS scores mean: adding an adjective rating scale. J User Exp. 2009;4:114\u201323.","journal-title":"J User Exp."},{"key":"5436_CR27","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1186\/1475-2875-12-286","volume":"12","author":"M Kahn","year":"2013","unstructured":"Kahn M, LaRue N, Bansil P, Kalnoky M, McGray S, Domingo GJ. Cryopreservation of glucose-6-phosphate dehydrogenase activity inside red blood cells: developing a specimen repository in support of development and evaluation of glucose-6-phosphate dehydrogenase deficiency tests. Malar J. 2013;12:286.","journal-title":"Malar J."},{"key":"5436_CR28","doi-asserted-by":"publisher","first-page":"213","DOI":"10.4269\/ajtmh.18-0612","volume":"100","author":"S Pal","year":"2019","unstructured":"Pal S, Bansil P, Bancone G, Hrutkay S, Kahn M, Gornsawun G, et al. Evaluation of a novel quantitative test for glucose-6-phosphate dehydrogenase deficiency: bringing quantitative testing for glucose-6-phosphate dehydrogenase deficiency closer to the patient. Am J Trop Med Hyg. 2019;100:213\u201321.","journal-title":"Am J Trop Med Hyg."}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-025-05436-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12936-025-05436-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-025-05436-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T05:24:40Z","timestamp":1751347480000},"score":1,"resource":{"primary":{"URL":"https:\/\/malariajournal.biomedcentral.com\/articles\/10.1186\/s12936-025-05436-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,1]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5436"],"URL":"https:\/\/doi.org\/10.1186\/s12936-025-05436-0","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5633356\/v1","asserted-by":"object"}]},"ISSN":["1475-2875"],"issn-type":[{"value":"1475-2875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,1]]},"assertion":[{"value":"12 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This research was approved with written informed consent by The Ethics Committee of the Faculty of Tropical Medicine \u2013 Mahidol University (Ref. No. TMEC 20-070; Bangkok, Thailand), Oxford Tropical Research Ethics Committee (Ref. No. 566-20; Oxford, England), and WCG IRB (Ref. No. 1300295 and 1329637; Puyallup, Washington, USA).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"201"}}